PCMC
Public Company Management Corp.0.2160
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
7.40MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
8-K
Authorized shares restated
Public Company Management Corporation amended Article 4 of its Articles of Incorporation on February 28, 2026, restating authorized capital at 500M common shares and 50M preferred shares, par value $0.001 each. A 70.3% stockholder approved via written consent. No new shares issued yet. Effective post-20-day notice period.
8-K
Shell inks LOI for healthcare buy
Public Company Management Corporation, a reporting shell, signed a non-binding LOI on February 23, 2026, to acquire Physicians Capital Management Corporation, which acquires and develops healthcare facilities for long-term net leases. Physicians' shareholders would own ~80% of PCMC post-deal, with Conrad Ivie, M.D., becoming Chairman and CEO. It's non-binding; due diligence and definitive agreement pending. Shell status triggers Super 8-K filing.
10-Q
Q1 FY2026 results
Public Company Management Corporation posted zero revenue for Q1 FY2026 ended December 31, 2025, trimming operating expenses to $16,350 from $17,712 y/y while net loss narrowed to $17,023 from $20,337, thanks to $1,952 interest income offsetting steady $2,625 interest expense on related-party debt. Cash drained to $71,555 from $234,405 q/q amid $32,850 operating outflow and $130,000 note receivable funding; total debt stands at $350,000 (3% note to Specialty Capital Lenders LLC, due Dec 31, 2026) with $97,154 accrued interest. Stockholders' deficit widened slightly to $224,184. No free cash flow disclosed. Ongoing merger talks with Physicians Capital Management risk due diligence snags.
10-K
FY2025 results
Public Company Management Corporation, a shell seeking a business combination, posted zero revenues for FY2025 ended September 30, 2025, with operating expenses climbing 32% y/y to $93,554 from $71,017, yielding a net loss of $103,817 versus $81,517 prior year; no Q4 breakdowns disclosed. Cash swelled to $234,405 from $100,035, fueled by $300,000 contributed capital, while negative operating cash flow hit $165,630. Related-party debt persists at $350,000 note plus $94,529 interest, maturity extended to December 2026. No guidance issued. Auditors flag going concern doubts due to accumulated deficit topping $5.7M.
8-K
Auditor switch after resignation
Public Company Management Corporation's auditor Hudgens CPA resigned December 30, 2025, after ceasing operations; prior reports were clean but flagged going concern doubts from losses and capital deficits. Board swiftly engaged L J Soldinger Associates as replacement on December 31. No disagreements or reportable events. Filing delays stemmed from EDGAR Next enrollment lag.
IPO
Sector
Industry
ADMG
ADAMANT DRI PROCESSING & MINLS
0.03+0.00
ATMC
AlphaTime Acquisition Corp
14.90+0.00
HCMA
HCM III Acquisition Corp.
10.08-0.01
PCSC
Perceptive Capital Solutions Co
11.80-0.43
PGAC
Pantages Capital Acquisition Co
10.37+0.00
PLMK
Plum Acquisition Corp. IV
10.43+0.00
PMVC
PMV Consumer Acquisition Corp.
438.80+0.00
TBMC
Trailblazer Merger Corporation
12.01-0.48
TCRI
TECHCOM INC.
0.17-0.00
VCIC
Vine Hill Capital Investment Co
10.75+0.03